Dragunsky EM - Search Results

1

Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.

Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM. Dragunsky EM, et al. J Infect Dis. 2004 Oct 15;190(8):1404-12. doi: 10.1086/424524. Epub 2004 Sep 20. J Infect Dis. 2004. PMID: 15378432

2

ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.

Ivanov AP, Dragunsky EM. Ivanov AP, et al. Among authors: dragunsky em. Expert Rev Vaccines. 2005 Apr;4(2):167-72. doi: 10.1586/14760584.4.2.167. Expert Rev Vaccines. 2005. PMID: 15889990 Free article. Review.

3

1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.

Ivanov AP, Dragunsky EM, Chumakov KM. Ivanov AP, et al. Among authors: dragunsky em. J Infect Dis. 2006 Feb 15;193(4):598-600. doi: 10.1086/499970. Epub 2006 Jan 12. J Infect Dis. 2006. PMID: 16425140

4

Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.

Dragunsky EM, Ivanov AP, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM. Dragunsky EM, et al. J Infect Dis. 2006 Sep 15;194(6):804-7. doi: 10.1086/506949. Epub 2006 Aug 16. J Infect Dis. 2006. PMID: 16941347

5

Immunogenicity of inactivated polio vaccine with concurrent antiviral V-073 administration in mice.

Kouiavskaia D, Collett MS, Dragunsky EM, Sarafanov A, Chumakov KM. Kouiavskaia D, et al. Among authors: dragunsky em. Clin Vaccine Immunol. 2011 Aug;18(8):1387-90. doi: 10.1128/CVI.05147-11. Epub 2011 Jun 29. Clin Vaccine Immunol. 2011. PMID: 21715577 Free PMC article.

6

Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.

Kouiavskaia DV, Dragunsky EM, Liu HM, Oberste MS, Collett MS, Chumakov KM. Kouiavskaia DV, et al. Among authors: dragunsky em. Antivir Ther. 2011;16(7):999-1004. doi: 10.3851/IMP1838. Antivir Ther. 2011. PMID: 22024515

7

Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).

Rezapkin G, Dragunsky E, Chumakov K. Rezapkin G, et al. Biologicals. 2005 Mar;33(1):17-27. doi: 10.1016/j.biologicals.2004.11.003. Biologicals. 2005. PMID: 15713553

8

Determination of poliovirus-specific IgA in saliva by ELISA tests.

Ivanov A, Dragunsky E, Ivanova O, Rezapkin G, Potapova S, Chumakov K. Ivanov A, et al. J Virol Methods. 2005 Jun;126(1-2):45-52. doi: 10.1016/j.jviromet.2005.01.030. J Virol Methods. 2005. PMID: 15847918

9

Repertoire of antibodies against type 1 poliovirus in human sera.

Rezapkin G, Neverov A, Cherkasova E, Vidor E, Sarafanov A, Kouiavskaia D, Dragunsky E, Chumakov K. Rezapkin G, et al. J Virol Methods. 2010 Nov;169(2):322-31. doi: 10.1016/j.jviromet.2010.07.037. Epub 2010 Aug 4. J Virol Methods. 2010. PMID: 20691212

10

Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.

Kouiavskaia D, Mirochnitchenko O, Dragunsky E, Kochba E, Levin Y, Troy S, Chumakov K. Kouiavskaia D, et al. J Infect Dis. 2015 May 1;211(9):1447-50. doi: 10.1093/infdis/jiu624. Epub 2014 Nov 12. J Infect Dis. 2015. PMID: 25391313 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters